Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Antiplatelet and Anticoagulation Therapies

April 18, 2019 — A recent study found patients with atherosclerotic cardiovascular disease cut their risk of a second ...

Home April 18, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

April 16, 2019 — HonorHealth Research Institute announced the first patients have been enrolled in the SynIVUS-DAPT ...

Home April 16, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

April 15, 2019 — Despite national guidelines indicating statins can lower risk of heart attack and stroke, many patients ...

Home April 15, 2019
Home
News | Heart Failure

March 29, 2019 — The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of ...

Home March 29, 2019
Home
News | Pharmaceuticals

March 29, 2019 — Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and ...

Home March 29, 2019
Home
News | Heart Failure
March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril ...
Home March 27, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

March 25, 2019 — Patients who stopped taking aspirin one month after receiving a stent in the heart’s arteries but ...

Home March 25, 2019
Home
News | Pharmaceuticals

March 25, 2019 — Phase 3 results from Study 2, also known as CLEAR WISDOM, of bempedoic acid were recently presented at ...

Home March 25, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

March 19, 2019 — The Bristol-Myers Squibb-Pfizer Alliance announced results from the Phase 4 AUGUSTUS trial evaluating ...

Home March 19, 2019
Home
Feature | ACC

The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 ...

Home March 19, 2019
Home
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics

March 18, 2019 — The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a ...

Home March 18, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

February 19, 2019 — A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and ...

Home February 19, 2019
Home
Two of the top news items from January included news atrial fibrillation guidelines that now recommend new anticoagulants (NOACs) over warfarin, and the FDA warning hospitals about the increased mortality found in one study involving pacitaxel-eluting stents and balloon devices for the peripheral arteries.
Feature | Dave Fornell, Editor

February 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...

Home February 01, 2019
Home
News | Hypertension

January 31, 2019 — Researchers have mapped the active-state structure of the angiotensin II type 1 receptor, the target ...

Home January 31, 2019
Home
Rivaroxaban is among four new oral anticoagulants (NOAC) now recommended by atrial fibrillation guidelines over the old standard of warfarin.
Feature | Atrial Fibrillation
January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral ...
Home January 30, 2019
Home
Subscribe Now